Skip to content
JournalsWorldThe Global Research Discovery Platform
Login Sign Up

Academic Journal

Q1

MedComm

John Wiley and Sons Inc

United StatesBiochemistry (medical) (Q1); Cell Biology (Q1); Drug Discovery (Q1); Genetics (Q1); Genetics (clinical) (Q1); Immunology and Allergy (Q1); Oncology (Q1)ISSN-matched source record
Submission information ↗
Q1Ranking
—Impact Factor (year unverified)
57H-index (SCImago 2025)
2.93SJR (2025)
2020-2026Coverage

About MedComm

MedComm is a scholarly journal published by John Wiley and Sons Inc. SCImago 2025 lists it in Q1, with an SJR of 2.93 and H-index of 57.

Coverage: 2020-2026. Research categories: Biochemistry (medical) (Q1); Cell Biology (Q1); Drug Discovery (Q1); Genetics (Q1); Genetics (clinical) (Q1); Immunology and Allergy (Q1); Oncology (Q1).

Open-access policies and author information

Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-03-17. This snapshot does not establish today’s listing status or fee quotation.

Accepted manuscript languagesEnglish
Licence optionsCC BY
Peer-review processAnonymous peer review
APCDOAJ-reported APC: 3850 USD; 2810 GBP; 3360 EUR
Waiver policy reportedYes
Other fees reportedNo
Author retains unrestricted copyrightYes
Digital preservationCLOCKSS, Portico, PMC
Reported submission-to-publication time10 weeks on average; not a guarantee
Openly licensed content since2020 (not the journal founding year)

Publisher policy links recorded by DOAJ

Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.

Source-backed journal facts

ISSN(s)2688-2663
ISSN-L2688-2663
Source typeJournal
Publisher / hosting organisationWiley
Publisher country codeCN
Fully open access (OpenAlex)Yes
DOAJ flag (OpenAlex)Listed in OpenAlex metadata; confirm current status in DOAJ
Works recorded in OpenAlex1,828
Citations recorded in OpenAlex34,128
OpenAlex H-index81
Years represented in OpenAlex1976–2026 (not the founding or closing dates)

Topics in published research

Cancer Immunotherapy and Biomarkers; Immune cells in cancer; RNA modifications and cancer; SARS-CoV-2 and COVID-19 Research; Epigenetics and DNA Methylation; Ferroptosis and cancer prognosis.

OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.

Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.

Found incorrect or outdated information?Help us keep this profile accurate.
Suggest an Edit